Natural History of Pathologically Benign Cancer Suspicious Regions on Multiparametric Magnetic Resonance Imaging Following Targeted Biopsy

2015 ◽  
Vol 194 (5) ◽  
pp. 1234-1240 ◽  
Author(s):  
Darren J. Bryk ◽  
Elton Llukani ◽  
William C. Huang ◽  
Herbert Lepor
2015 ◽  
Vol 193 (4S) ◽  
Author(s):  
Raju Chelluri ◽  
Thomas Frye ◽  
Arvin K. George ◽  
Michele Fascelli ◽  
Richard Ho ◽  
...  

2018 ◽  
Vol 12 (8) ◽  
Author(s):  
Samrad Ghavimi ◽  
Hamidreza Abdi ◽  
Jennifer Waterhouse ◽  
Richard Savdie ◽  
Silvia Chang ◽  
...  

Introduction: The natural history of prostatic lesions identified on multiparametric magnetic resonance imaging (mpMRI) is largely unknown. We aimed to describe changes observed over time on serial MRI.Methods: All patients with ≥2 MRI studies between 2008 and 2015 at our institution were identified. MRI progression was defined as an increase in Prostate Imaging Reporting and Data System (PI-RADS; version 2) or size of existing lesions, or the appearance of a new lesion PIRADS ≥4. Patients on active surveillance (AS) were analyzed for correlation of MRI progression to biopsy reclassification.Results: A total of 83 patients (54 on AS and 29 for diagnostic purposes) underwent serial MRI, with a mean interval of 1.9 years between scans. At baseline, 115 lesions (66 index, 49 non-index) were identified. Index lesions were more likely than non-index lesions to increase in size ≥2 mm (36.2 vs. 7.3%; p=0.002). Overall progression was more likely to be seen among the index cohort (34.8 vs. 7.6%; p<0.001). New lesions with PI-RADS ≥4 were seen on second imaging in 13 (16.5%) men, and became the index lesion in 29 cases (34.9%). Eighteen men on AS showed evidence of MRI progression (five with new lesions, 13 with progression of a previous lesion). Biopsy reclassification was present in three men (16.7%) with and seven men without MRI progression (19.4%).Conclusions: Overall changes in size and PI-RADS scores of index lesions on MRI were small. New lesions were common, but usually did not alter management.


The Lancet ◽  
1998 ◽  
Vol 351 (9105) ◽  
pp. 801-802 ◽  
Author(s):  
Michael Douek ◽  
Jayant S Vaidya ◽  
Sunil R Lakhani ◽  
Margaret A Hall-Craggs ◽  
Michael Baum ◽  
...  

2017 ◽  
Vol 11 (1-2) ◽  
pp. 1 ◽  
Author(s):  
Masoom A. Haider ◽  
Xiaomei Yao ◽  
Andrew Loblaw ◽  
Antonio Finelli

This clinical guideline focuses on: 1) the use of multiparametric magnetic resonance imaging (mpMRI) in diagnosing clinically significant prostate cancer (CSPC) in patients with an elevated risk of CSPC and who are biopsy-naïve; and 2) the use of mpMRI in diagnosing CSPC in patients with a persistently elevated risk of having CSPC and who have a negative transrectal ultrasound (TRUS)-guided systematic biopsy.The methods of the Practice Guideline Development Cycle were used. MEDLINE, EMBASE, the Cochrane Library (1997‒April 2014), main guideline websites, and relevant annual meeting abstracts (2011‒2014) were searched. Internal and external reviews were conducted.The two main recommendations are:Recommendation 1: In patients with an elevated risk of CSPC (according to prostate-specific antigen [PSA] levels and/or nomograms) who are biopsy-naïve: mpMRI followed by targeted biopsy (biopsy directed at cancer-suspicious foci detected with mpMRI) should not be considered the standard of care; data from future research studies are essential and should receive high-impact trial funding to determine the value of mpMRI in this clinical context.Recommendation 2:In patients who had a prior negative TRUS-guided systematic biopsy and demonstrate an increasing risk of having CSPC since prior biopsy (e.g., continued rise in PSA and/or change in findings from digital rectal examination): mpMRI followed by targeted biopsy may be considered to help in detecting more CSPC patients compared with repeated TRUS-guided systematic biopsy.


2005 ◽  
Vol 18 (2) ◽  
pp. 121-126 ◽  
Author(s):  
Tetsuo Masui ◽  
Yasutsugu Yukawa ◽  
Shigeru Nakamura ◽  
Gakuji Kajino ◽  
Yuji Matsubara ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document